Antagonism by class I antiarrhythmic drugs of levcromakalim-induced relaxation in isolated rat aorta

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 81-86

  Cogolludo, Angel L ^a   Perez Vizcaino, Francisco ^a   Tamargo, Juan ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; DISOPYRAMIDE; FLECAINIDE; GLIBENCLAMIDE; LEMAKALIM; MEXILETINE; PROPAFENONE; QUINIDINE; TETRYLAMMONIUM;

ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CONCENTRATION RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ISOLATED ORGAN; NONHUMAN; PANCREAS ISLET BETA CELL; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SMOOTH MUSCLE RELAXATION; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; AORTA, THORACIC; CROMAKALIM; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; POTASSIUM CHANNELS; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; TETRAETHYLAMMONIUM COMPOUNDS; VASODILATION;

EID: 0032455467     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:282-293.
2. + channels. Cell Signal 2:197-214.
3. Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606-718.
4. + channels in mouse pancreatic β cells by external tetraethylammonium and quinine. J Physiol (Lond) 423:327-342.
5. + efflux-stimulating and vasorelaxant properties of cromakalim. Eur J Pharmacol 200:163-165.
6. + channel openers in rat aorta. J Biol Chem 267:11689-11692.
7. 45Ca movements and contractile responses in vascular smooth muscle. Br J Pharmacol 103:1453-1457.
8. Daut J, Maier-Rudolph W, Von Beckerath N, Mehrke G, Gunther K and Goedel-Meinen L (1990) Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247:1341-1344.
9. + current by the class Ia agent disopyramide in cat ventricular myocytes. J Pharmacol Exp Ther 272:714-723.
10. Delgado C, Tamargo J, Henzel D and Lorente P (1993) Effects of propafenone on calcium currents in guinea-pig ventricular myocytes. Br J Pharmacol 108:721-727.
11. + current in guinea-pig ventricular myocytes: voltage-independent and time-dependent block of the slowly activating component. Circ Res 76:223-235.
12. Edwards G and Weston AH (1993) The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 33:597-637.
13. Edwards G and Weston AH (1995) Potassium channels in the regulation of vascular smooth muscle tone, in Pharmacological Control of Calcium and Potassium Homeostasis (Godfraind T, Mancia G, Abracchio MP, Aguilar-Bryan L and Govoni S eds) pp 85-94, Kluwer Academic Publishers, London.
14. Elharrar V, Gawm WE and Zipes D (1977) Effects of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute occlusion in dogs. Am J Cardiol 39:544-549.
15. Etch DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L and Greene HL (1991) Mortality and morbidity in patients receiving encamide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trail. N Engl J Med 324:781-788.
16. Fernandez del Pozo B, Fernandez Montero C, Perez-Vizcaino F, Zaragoza F and Tamargo J (1997) Effects of several class I antiarrhythmic drugs on isolated rat aortic vascular smooth muscle. Gen Pharmacol 29:539-543.
17. Fernandez del Pozo B, Perez-Vizcaino F, Villamor E, Zaragoza F and Tamargo J (1996) Stereoselective effects of the enantiomers quinidine and quinine on depolarization and agonist-mediated responses in isolated rat aorta. Br J Pharmacol 117:105-110.
18. 3H]Glyburide, to neuronal and muscle preparations. J Pharmacol Exp Ther 257:1162-1171.
19. Guillemare E, Lazdunski M and Honore E (1995) Glibenclamide opens ATP-sensitive potassium channels in Xenopus oocyte follicular cells during metabolic stress. Mol Pharmacol 47:588-594.
20. ATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 270:1166-1170.
21. + channels. Am J Physiol 261:C583-C590.
22. 2+ channels of myocardial cells. Jpn Circ J 52:238-242.
23. + channels of mouse skeletal muscle by disopyramide. Eur J Pharmacol 284:35-41.
24. Nattel S, Pedersen DH and Zipes DP (1981) Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog. Cardiovasc Res 15:80-85.
25. Perez-Vizcaino F, Casis O, Rodriguez R, Gomez GA, Garcia-Rafanell J and Tamargo J (1993) Effects of the novel potassium channel opener UR-8225 in rat vascular smooth muscle. Br J Pharmacol 110:1165-1171.
26. Perez-Vizcaino F, Duarte J and Tamargo J (1991) Effects of flecainide on isolated vascular smooth muscles of rat. Br J Pharmacol 104:726-730.
27. Perez-Vizcaino F, Fernandez del Pozo B, Zaragoza F and Tamargo J (1994) Voltage-and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine. Br J Pharmacol 113:1281-1288.
28. 2 mimetic U46619. Br J Pharmacol 121:1323-1333.
29. Podrid PJ and Fogel RI (1992) Aggravation of arrhythmia by antiarrhythmic drugs, and the important role of underlaying ischemia. Am J Cardiol 70:100-102.
30. + channels? Trends Pharmacol Sci 141:332-337.
31. Richer C, Pratz J, Mulder P, Mondot S, Giudicelli JF and Cavero I (1990) Cardiovascular and biological effects of potassium channel openers, a class of drugs with vasorelaxant and cardioprotective properties. Life Sci 47:1693-1705.
32. Roden DM (1996) Antiarrhythmic drugs, in The pharmacological basis of therapeutics (Hardman JG, Limbird LE, Molinoff PB, Ruddon RW and Goodman Gilman A eds) pp 839-874, McGraw-Hill, New York.
33. + channels in Xenopus oocytes. Br J Pharmacol 107: 1061-1067.
34. Salata JJ and Wasserstrom JA (1988) Effects of quinidine on action potentials and ionic currents in isolated canine ventricular myocytes. Circ Res 62:324-337.
35. Samaha FF, Heineman FW, Ince C, Fleming J and Balaban RS (1992) ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am J Physiol 262:C1220-C1227.
36. + channels. Br J Pharmacol 115:381-382.
37. Ca in single frog cardiac cells by quinidine, flecainide, ethmozin and ethacizin. Am J Physiol 256:C549-C559.
38. + channel blocking actions of flecainide compared to those of propafenone and quinidine in adult rat ventricular myocytes. J Pharmacol Exp Ther 269:66-72.
39. Snyders DJ and Yeola SW (1995) Determinants of antiarrhythmic drugs action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ Res 77:575-583.
40. Tamargo J, Valenzuela C and Delpon E (1992) New insights into the pharmacology of sodium channel blockers. Eur Heart J 13(suppl F):2-13.
41. Teo KK, Yusuf S and Furberg CD (1993) Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 270:1589-1595.
42. Vaughan Williams EM (1984) Classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 24:129-147.
43. + channel. Science 251:939-942.